Moffitt Cancer Center and Memorial Healthcare System (MHS) have entered into a clinical partnership that will enhance the care of leukemia and lymphoma and establish a comprehensive Blood and Marrow Transplant Cellular Therapy Program for South Florida residents starting July 1. With both institutions recognized nationally and internationally as leaders in cancer care, this collaboration provides major benefits to patients seeking highly specialized cancer care close to home.
Moffitt has a lasting commitment to the prevention and cure of cancer, through patient care, scientific discovery and education. That includes bringing these components to areas outside the Tampa region. MHS has been a leader in providing high-quality health care services to South Florida with a caring philosophy to treat the whole patient – physically, emotionally and psychologically – through an integrated treatment approach that includes services from pain and symptom management to social services and support groups.
Through the partnership, Moffitt will provide services of blood and marrow transplant and malignant hematology as well as those related to molecular diagnostics, personalized medicine and hematopathology. Moffitt will employ the physicians and advanced practice professionals to staff the new program at MHS.